![]() |
市场调查报告书
商品编码
1790283
美国一次性套管针市场:按尖端、应用和细分市场进行趋势分析:2025 年至 2033 年U.S. Disposable Trocars Market Size, Share & Trends Analysis Report By Tip, By Application, And Segment Forecasts, 2025 - 2033 |
预计 2024 年美国一次性套管针市场规模为 1.3511 亿美元,到 2033 年将达到 2.0962 亿美元,2025 年至 2033 年的复合年增长率为 5.00%。
市场成长的动力来自于全国大量的微创外科手术,例如腹腔镜手术、减重手术、泌尿系统手术和泌尿外科手术,这些手术需要可靠的无菌通路设备。门诊手术中心 (ASC) 的快速扩张使得感染控制、效率和周转时间成为重中之重,进一步加速了对一次性套管针的需求。此外,医院越来越多地采用达文西平台等机器人辅助手术系统,也推动了对先进光学和无刀片套管针的需求,以确保精度和相容性。严格的 FDA 感染控制法规和后疫情时代对无菌性的重视,使得一次性选择比可重复使用选择更具吸引力。同时,通用密封件和低剖面套管等持续的技术创新正在增加外科医生的偏好并推动市场成长。
美国医院越来越多地采用机器人辅助系统,例如 Intuitive Surgical 的达文西平台,这推动了对精密手术器械的需求。这些手术依赖精确的套管针定位,而光学和专用的一次性套管针与机器人器械无缝集成,使其受益匪浅。随着先进的可视化和导航技术在外科手术中日益普及,对高性能、可增强控制性、稳定性和相容性的套管针的需求也日益增长,这使得一次性套管针在机器人辅助手术中越来越受欢迎。
美国门诊手术中心 (ASC) 的快速发展推动了对一次性手术器械(尤其是套管针)的需求。 ASC 致力于最大限度地提高效率、保持无菌并降低成本,他们发现一次性套管针是符合其业务的实用解决方案。这些中心处理大量门诊手术,例如疝气修补和妇科手术,一次性套管针有助于缩短週转时间并消除复杂的灭菌流程,最终提高手术量并保障患者安全。
美国癌症发生率的上升是一次性套管针市场的主要驱动力,因为许多肿瘤手术,例如腹腔镜切除术、子宫切除术和切除术,都需要微创手术入路。癌症患者人数逐年增加,尤其是在高龄化社会,这推动了对安全、无菌和高效手术器械的需求。一次性套管针在这些手术中被广泛使用,因为它们可以降低感染风险,支持复杂的手术导引,并符合医院的肿瘤治疗通讯协定。它们与机器人辅助系统和先进影像处理的兼容性,使其成为需要高精度和高控制力的癌症手术的理想选择。
无叶片套管针技术的创新,例如无叶片尖端、光学插入系统、径向可扩展套管以及通用密封阀,显着提高了安全性、精准度和外科医生的人体工学。例如,主要医疗设备製造商开发的无叶片套管针因其能够最大限度地减少插入力和组织损伤而广受欢迎,目前已广泛应用于腹腔镜手术和机器人辅助手术。
The U.S. disposable trocars market size was estimated at USD 135.11 million in 2024 and is projected to reach USD 209.62 million by 2033, growing at a CAGR of 5.00% from 2025 to 2033. The market growth is attributed to the country's high volume of minimally invasive surgical procedures, including laparoscopic, bariatric, gynecological, and urological surgeries requiring reliable and sterile access devices. The rapid expansion of ambulatory surgical centers (ASCs), where infection control, efficiency, and turnaround time are top priorities, further accelerates the demand for single-use trocars. In addition, the growing integration of robotic-assisted surgical systems in hospitals, such as the da Vinci platform, has fueled the need for advanced optical and bladeless trocars that ensure precision and compatibility. Strict FDA infection control regulations and post-COVID emphasis on sterility have made disposable options more attractive than reusable ones, while ongoing technological innovations, such as universal seals and low-profile cannulas, enhance surgeon preference and drive market growth.
The growing adoption of robotic-assisted systems such as Intuitive Surgical's da Vinci platform in U.S. hospitals drives demand for precision-compatible surgical tools. These procedures rely on accurate trocar placement and benefit significantly from optical and specialized disposable trocars that integrate seamlessly with robotic instruments. As advanced visualization and navigation technologies become more common in surgery, there is a rising need for high-performance trocars that offer enhanced control, stability, and compatibility, making disposable options increasingly preferred in robotic-assisted procedures.
The rapid growth of Ambulatory Surgical Centers (ASCs) in the U.S. fuels demand for disposable surgical devices, particularly trocars. Focused on maximizing efficiency, maintaining sterility, and reducing costs, ASCs find single-use trocars to be a practical solution that aligns with their workflow. These centers handle a high volume of outpatient procedures, such as hernia repairs and gynecological surgeries, where disposable trocars help reduce turnaround times and eliminate the need for complex sterilization processes, ultimately enhancing operational throughput and patient safety.
The rising prevalence of cancer in the U.S. is a significant driver of the disposable trocars market, as many oncologic procedures, such as laparoscopic colectomies, hysterectomies, and prostatectomies, require minimally invasive surgical access. With cancer cases increasing annually, particularly among the aging population, the demand for safe, sterile, and efficient surgical tools is growing. Disposable trocars are widely used in these procedures because they reduce the risk of infection, support complex surgical navigation, and align with hospital protocols for oncology care. Their compatibility with robotic-assisted systems and advanced imaging makes them ideal for cancer surgeries requiring high precision and control.
Innovation in trocar technology, such as bladeless tips, optical entry systems, radially expandable cannulas, and universal sealing valves, has significantly improved safety, precision, and surgeon ergonomics. These advancements contribute to better procedural outcomes and are increasingly adopted by leading hospitals across the U.S. For instance, a major medical device company's widely used bladeless trocar design has gained popularity for its ability to minimize insertion force and reduce tissue trauma, making it a preferred option in both laparoscopic and robotic-assisted surgeries.
U.S Disposable Trocars Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. disposable trocars market report on the basis of application, and tip: